Prokidney (PROK) Non-Current Assets (2021 - 2026)

Prokidney (PROK) reported Non-Current Assets of $57.9 million for Q1 2026, up 24.75% year-over-year from $46.4 million in Q1 2025, and up 5.44% quarter-over-quarter from $54.9 million in Q4 2025.

Prokidney (PROK) Non-Current Assets (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Non-Current Assets data on file, last reported at $57.9 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $57.9 million, up 24.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $212.1 million (up 14.61% YoY), and the FY2025 annual result was $54.9 million, up 21.48% from the prior year.
  • Non-Current Assets grew to $57.9 million in Q1 2026 per PROK's latest filing, from $54.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $250.4 million in Q2 2022 and troughed at $13.1 million in Q3 2022.
  • A 5-year average of $64.5 million and a median of $46.4 million in 2023 frame the typical range for Non-Current Assets.
  • On a YoY basis, Non-Current Assets climbed as much as 65845.09% in 2022 and fell as far as 94.77% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $13.3 million in 2022, then jumped by 249.52% to $46.4 million in 2023, then declined by 2.62% to $45.2 million in 2024, then grew by 21.48% to $54.9 million in 2025, then grew by 5.44% to $57.9 million in 2026.
  • Business Quant data shows PROK's Non-Current Assets at $57.9 million in Q1 2026, $54.9 million in Q4 2025, and $51.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Prokidney 259.01 Mn 1.55 Bn - 57.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.88 Mn
Dec 31, 2025 54.90 Mn
Sep 30, 2025 51.62 Mn
Jun 30, 2025 47.69 Mn
Mar 31, 2025 46.40 Mn
Dec 31, 2024 45.19 Mn
Sep 30, 2024 44.57 Mn
Jun 30, 2024 48.90 Mn
Mar 31, 2024 47.61 Mn
Dec 31, 2023 46.41 Mn
Sep 30, 2023 45.38 Mn
Jun 30, 2023 17.79 Mn
Mar 31, 2023 15.01 Mn
Dec 31, 2022 13.28 Mn
Sep 30, 2022 13.07 Mn
Jun 30, 2022 250.37 Mn
Mar 31, 2022 250.16 Mn
Dec 31, 2021 13.03 Mn
Sep 30, 2021 250.00 Mn
Jun 30, 2021 379,666.00